The CPHI Frankfurt 2025 exhibition successfully concluded at the Messe Frankfurt Exhibition Center, bringing together leading companies and professionals from across the global pharmaceutical industry.
Xi’an Deli Biochemical Industry Co., Ltd. proudly showcased its latest innovations at Booth 8.0P30, presenting a comprehensive range of products including Hydroxypropyl Betadex (HPBCD), Betadex Sulfobutyl Ether Sodium (SBECD), Glucosamine Sulfate Sodium Chloride, Menatetrenone and Icodextrin.
Throughout the three-day event, Deli Biochemical’s booth attracted a large number of international visitors from France, Germany, Korea, India, and many other countries. The company’s team engaged in fruitful discussions with pharmaceutical manufacturers, cosmetic companies, and trading partners, exploring opportunities for collaboration in formulation development, solubilization enhancement, and active ingredient stabilization.
As a leading manufacturer with over 24 years of experience, Deli Biochemical specializes in cyclodextrin derivatives and biochemical ingredients widely used in pharmaceuticals, cosmetics, and veterinary applications. The company’s products are known for their high purity, consistent quality, and reliable performance, meeting the strict requirements of global markets.
During the exhibition, Deli Biochemical also introduced new product applications and shared insights into sustainable and efficient production technologies, reflecting its continuous commitment to innovation, quality, and global partnership.